Target intelligence / Profile preview

Thyroid hormone receptor-associated protein 3 (THRAP3)

Target
THRAP3
Molecular classification
Other (transcription coactivator, splicing factor, component of exon-junction and SNARP complexes)
01

Overview

Thyroid hormone receptor-associated protein 3 (THRAP3) is a nuclear protein that functions in pre-mRNA splicing and remains associated with spliced mRNA, likely interacting with the exon junction complex[1][3][4]. It acts as a transcription coactivator, notably enhancing the activity of the CLOCK-BMAL1 heterodimer on circadian gene targets, and participates in the positive regulation of the circadian clock[1][6]. THRAP3 is implicated in the stability of specific mRNAs, regulation of gene expression, alternative splicing, response to DNA damage, and mRNA decay[1][3][4]. It is not considered a classical drug target such as a receptor or an enzyme, but alterations in its function have been associated with certain cancers, including soft tissue sarcoma and telangiectatic osteogenic sarcoma[1]. Common alternative names and aliases include TRAP150 and BCLAF2[1][2].

Other names
TRAP150BCLAF2BCLAF1 and THRAP3 family member 2Thyroid hormone receptor-associated protein complex 150 kDa componentTR-associated protein, 150-kDaSNARP complex component
02

Biological functions

Transcription coactivator activityRNA bindingPre-mRNA splicingRegulation of gene expressionmRNA decayRegulation of circadian rhythmResponse to DNA damage
03

Disease associations

CancerSoft tissue sarcomaTelangiectatic osteogenic sarcoma

Beyond the preview

Go deeper on Thyroid hormone receptor-associated protein 3 (THRAP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thyroid hormone receptor-associated protein 3 (THRAP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call